novo nordisk semaglutide tablet medicines containing Novo Nordisk launches its Wegovy

Employers and health providers must consider this shift, designing programs that nurture sustainable, health-focused habits, not just weight reduction

Alternatives save tens of thousands annually

Adv Pharmacol 82:5783

Breakup by Region: North America United States Canada Europe Germany France United Kingdom Italy Spain Others Asia Pacific China Japan India South Korea Australia Indonesia Others Latin America Brazil Mexico Others Middle East and Africa North America leads the market, accounting for the largest GLP-1 receptor agonist market share The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada)